?:authorAffiliation
|
-
[\'Division of Medical Virology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. Emmanuel.margolin@uct.ac.za.\', \'Wellcome Trust Centre for Infectious Disease Research in Africa, University of Cape Town, Cape Town, South Africa. Emmanuel.margolin@uct.ac.za.\', \'Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. Emmanuel.margolin@uct.ac.za.\', \'Biopharming Research Unit, Department of Molecular and Cell Biology, University of Cape Town, Cape Town, South Africa. Emmanuel.margolin@uct.ac.za.\', \'Division of Medical Virology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.\', \'Wellcome Trust Centre for Infectious Disease Research in Africa, University of Cape Town, Cape Town, South Africa.\', \'Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.\', \'Department of Integrative Biomedical Sciences, University of Cape Town, Cape Town, South Africa.\', \'Division of Infectious Diseases & HIV Medicine, Department of Medicine, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.\', \'Division of Medical Virology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. Ed.rybicki@uct.ac.za.\', \'Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. Ed.rybicki@uct.ac.za.\', \'Biopharming Research Unit, Department of Molecular and Cell Biology, University of Cape Town, Cape Town, South Africa. Ed.rybicki@uct.ac.za.\']
|